A machine learning lung cancer risk prediction model outperformed logistic regression, supporting improved risk assessment and more efficient radiology based lung cancer screening.
SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, today shared another ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback